Bedfont Scientific Limited has created a subsidiary, NoxBOX Limited, to concentrate on its successful range of Inhaled Nitric Oxide monitoring systems.
The new company has been created as part of Bedfont’s long-term development and expansion plans.
Established in 1976 in Kent, UK, Bedfont specialises in exhaled breath and gas monitors for the medical industry. The NOxBOX range was introduced by Bedfont in 1992 and is used to deliver and monitor inhaled nitric oxide (iNO) therapy.
iNO therapy is mainly used in intensive care units (ICU) to aid in the therapeutic care of premature babies and patients under severe respiratory distress. Using iNO therapy allows the blood supply to pick up oxygen from the lungs more readily by dilating the pulmonary arteries, making it the ideal method of treatment for pulmonary hypertension and other conditions that can lead to severe breathing difficulties.
... to continue reading you must be subscribed
